Yondelis Injection, Powder, Lyophilized, For Solution
Product Images NDC 59676-610

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Yondelis (NDC 59676-610). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Products, Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Yondelis 01)

FDA Label Image

Figure 1 (Yondelis 02)

Figure 1 (Yondelis 02)
This is a description of a clinical trial comparing the efficacy of two drugs, Dacarbazine and Yondelis. The text includes the number of subjects at risk in each group over a period of months. The text does not provide enough information to make any conclusions about the study.*
FDA Label Image

Principal Display Panel (1 Vial Carton)

Principal Display Panel (1 Vial Carton)
This is a description of a drug called Yondelis Y'. It is a trabectedin injection that contains 1mg per vial for intravenous infusion only. The product has been assigned an NDC code of 5967661001 and requires reconstitution before further use. It is a single-dose vial and any unused portion should be discharged as it is cytotoxic. The text has some characters and words that are not recognizable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.